Clinical trial
The Efficacy and Safety of Perirenal Adipose Tissue Modification Therapy by Focused Power Ultrasound for Resistant Hypertension
NCT07232966 is registered in ClinicalTrials.gov with Yan Li as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Efficacy and Safety of Perirenal Adipose Tissue Modification Therapy by Focused Power Ultrasound for Resistant Hypertension
- Lead sponsor
- Yan Li
- Phase
- Phase 3
- Overall status
- Not yet recruiting
- Start date
- November 20, 2025
- Completion date
- June 30, 2029
- Enrollment
- 220 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
resistant hypertension